The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease

Mitochondrion

Volumn 7, Issue SUPPL., 2007, Pages

  Haas, Richard H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coenzyme Q10; Evidence based medicine; Mitochondrial disease treatment; OXPHOS

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; ATORVASTATIN; CREATINE; MENADIONE; METHYLPREDNISOLONE; MITOCHONDRIAL DNA; NICOTINIC ACID; PLACEBO; RIBOFLAVIN; THIAMINE; THIOCTIC ACID; UBIDECARENONE; UBIQUINONE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CEREBELLAR ATAXIA; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG PENETRATION; DRUG SAFETY; DRUG TISSUE LEVEL; DRUG UPTAKE; EVIDENCE BASED MEDICINE; EXERCISE TEST; FRIEDREICH ATAXIA; GASTROINTESTINAL TOXICITY; GENE MUTATION; GENETIC CODE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HUMAN; HUNTINGTON CHOREA; LOW DRUG DOSE; META ANALYSIS; MULTIPLE CYCLE TREATMENT; MUTATIONAL ANALYSIS; MYOPATHY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; COENZYMES; EVIDENCE-BASED MEDICINE; GUINEA PIGS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MODELS, BIOLOGICAL; OXIDATIVE PHOSPHORYLATION; OXYGEN; PHOSPHORYLATION; RATS; UBIQUINONE;

EID: 34248175243     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2007.03.008     Document Type: Article

References (72)

1. Abe K., Matsuo Y., Kadekawa J., Inoue S., and Yanagihara T. Effect of coenzyme Q10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): evaluation by noninvasive tissue oximetry. J. Neurol. Sci. 162 (1999) 65-68
2. Artuch R., Brea-Calvo G., Briones P., Aracil A., Galvan M., Espinos C., Corral J., Volpini V., Ribes A., Andreu A.L., Palau F., Sanchez-alcazar J.A., Navas P., and Pineda M. Cerebellar ataxia with coenzyme Q10 deficiency: diagnosis and follow-up after coenzyme Q10 supplementation. J. Neurol. Sci. 246 (2006) 153-158
3. Barbiroli B., Frassineti C., Martinelli P., Iotti S., Lodi R., Cortelli P., and Montagna P. Coenzyme Q10 improves mitochondrial respiration in patients with mitochondrial cytopathies. An in vivo study on brain and skeletal muscle by phosphorous magnetic resonance spectroscopy. Cell. Mol. Biol. (Noisy-le-grand) 43 (1997) 741-749
4. Barshop B.A., Naviaux R.K., Mcgowan K.A., Levine F., Nyhan W.L., Loupis-Geller A., and Haas R.H. Chronic treatment of mitochondrial disease patients with dichloroacetate. Mol. Genet. Metab. 83 (2004) 138-149
5. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol. 58 (2005) 495-505
6. Bendahan D., Desnuelle C., Vanuxem D., Confort-Gouny S., Figarella-Branger D., Pellissier J.F., Kozak-Ribbens G., Pouget J., Serratrice G., and Cozzone P.J. 31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies. Neurology 42 (1992) 1203-1208
7. Bentinger M., Dallner G., Chojnacki T., and Swiezewska E. Distribution and breakdown of labeled coenzyme Q10 in rat. Free Radic. Biol. Med. 34 (2003) 563-575
8. Bernier F.P., Boneh A., Dennett X., Chow C.W., Cleary M.A., and Thorburn D.R. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59 (2002) 1406-1411
9. Boitier E., Degoul F., Desguerre I., Charpentier C., Francois D., Ponsot G., Diry M., Rustin P., and Marsac C. A case of mitochondrial encephalomyopathy associated with a muscle coenzyme Q10 deficiency. J. Neurol. Sci. 156 (1998) 41-46
10. Bresolin N., Bet L., Binda A., Moggio M., Comi G., Nador F., Ferrante C., Carenzi A., and Scarlato G. Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10. Neurology 38 (1988) 892-899
11. Bresolin N., Doriguzzi C., Ponzetto C., Angelini C., Moroni I., Castelli E., Cossutta E., Binda A., Gallanti A., Gabellini S., et al. Ubidecarenone in the treatment of mitochondrial myopathies: a multi-center double-blind trial. J. Neurol. Sci. 100 (1990) 70-78
12. Brown Melissa M., Brown Gary C., and Sanjay S. Evidence-Based to Value-Based Medicine (2005), AMA Press, Chicago
13. Chan A., Reichmann H., Kogel A., Beck A., and Gold R. Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy. J. Neurol. 245 (1998) 681-685
14. Chen R.S., Huang C.C., and Chu N.S. Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. Eur. Neurol. 37 (1997) 212-218
15. Chinnery, P., Majamaa, K., Turnbull, D., Thorburn, D., 2006. Treatment for mitochondrial disorders. Cochrane Database Syst. Rev., CD004426.
16. Corral-Debrinski M., Horton T., Lott M.T., Shoffner J.M., Beal M.F., and Wallace D.C. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nat. Genet. 2 (1992) 324-329
17. Corral-Debrinski M., Shoffner J.M., Lott M.T., and Wallace D.C. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. Mutat. Res. 275 (1992) 169-180
18. Desnuelle C., Pellissier J.F., Serratrice G., Pouget J., and Turnbull D.M. Kearns-Sayre syndrome: mitochondrial encephalomyopathy caused by deficiency of the respiratory chain. Rev. Neurol. (Paris) 145 (1989) 842-850
19. Di Giovanni S., Mirabella M., Spinazzola A., Crociani P., Silvestri G., Broccolini A., Tonali P., Di Mauro S., and Servidei S. Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology 57 (2001) 515-518
20. Evidenced Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. Evidence-Based Medicine Working Group. JAMA 268 (1992) 2420-2425
21. Ferrante K.L., Shefner J., Zhang H., Betensky R., O'brien M., Yu H., Fantasia M., Taft J., Beal M.F., Traynor B., Newhall K., Donofrio P., Caress J., Ashburn C., Freiberg B., O'neill C., Paladenech C., Walker T., Pestronk A., Abrams B., Florence J., Renna R., Schierbecker J., Malkus B., and Cudkowicz M. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS. Neurology 65 (2005) 1834-1836
22. Folkers K., and Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim. Biophys. Acta 1271 (1995) 281-286
23. Gold R., Seibel P., Reinelt G., Schindler R., Landwehr P., Beck A., and Reichmann H. Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q. Eur. Neurol. 36 (1996) 191-196
24. Hart P.E., Lodi R., Rajagopalan B., Bradley J.L., Crilley J.G., Turner C., Blamire A.M., Manners D., Styles P., Schapira A.H., and Cooper J.M. Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up. Arch. Neurol. 62 (2005) 621-626
25. Huntington's Study Group. A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease. Neurology 57 (2001) 397-404
26. Huntington Study Group (2005) PRE2CARE: A dosage ranging trial of CoEnzymeQ10 in Huntington's disease and normal subjects. HDF Biennial Symposia. Cambridge, MA.
27. Kamzalov S., Sumien N., Forster M.J., and Sohal R.S. Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice. J. Nutr. 133 (2003) 3175-3180
28. Kaufmann P., Engelstad K., Wei Y., Jhung S., Sano M.C., Shungu D.C., Millar W.S., Hong X., Gooch C.L., Mao X., Pascual J.M., Hirano M., Stacpoole P.W., Dimauro S., and De Vivo D.C. Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology 66 (2006) 324-330
29. Koroshetz W.J., Jenkins B.G., Rosen B.R., and Beal M.F. Energy metabolism defects in Huntington's disease and effects of coenzyme Q10. Ann. Neurol. 41 (1997) 160-165
30. Kwong L.K., Kamzalov S., Rebrin I., Bayne A.C., Jana C.K., Morris P., Forster M.J., and Sohal R.S. Effects of coenzyme Q(10) administration on its tissue concentrations, mitochondrial oxidant generation, and oxidative stress in the rat. Free Radic. Biol. Med. 33 (2002) 627-638
31. Lalani S.R., Vladutiu G.D., Plunkett K., Lotze T.E., Adesina A.M., and Scaglia F. Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency. Arch. Neurol. 62 (2005) 317-320
32. Lamperti C., Naini A.B., Lucchini V., Prelle A., Bresolin N., Moggio M., Sciacco M., Kaufmann P., and Dimauro S. Muscle coenzyme Q10 level in statin-related myopathy. Arch. Neurol. 62 (2005) 1709-1712
33. Lass A., Forster M.J., and Sohal R.S. Effects of coenzyme Q10 and alpha-tocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radic. Biol. Med. 26 (1999) 1375-1382
34. Low P., Andersson M., Edlund C., and Dallner G. Effects of mevinolin treatment on tissue dolichol and ubiquinone levels in the rat. Biochim. Biophys. Acta 1165 (1992) 102-109
35. Manzoli U., Rossi E., Littarru G.P., Frustaci A., Lippa S., Oradei A., and Aureli V. Coenzyme Q10 in dilated cardiomyopathy. Int. J. Tissue React. 12 (1990) 173-178
36. Matsuoka T., Maeda H., Goto Y., and Nonaka I. Muscle coenzyme Q10 in mitochondrial encephalomyopathies. Neuromuscul. Disord. 1 (1991) 443-447
37. Matthews P.M., Ford B., Dandurand R.J., Eidelman D.H., O'connor D., Sherwin A., Karpati G., Andermann F., and Arnold D.L. Coenzyme Q10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease. Neurology 43 (1993) 884-890
38. Mckenzie M., Liolitsa D., and Hanna M.G. Mitochondrial disease: mutations and mechanisms. Neurochem. Res. 29 (2004) 589-600
39. Mecocci P., Macgarvey U., Kaufman A.E., Koontz D., Shoffner J.M., Wallace D.C., and Beal M.F. Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann. Neurol. 34 (1993) 609-616
40. Miles L., Miles M.V., Tang P.H., Horn P.S., Wong B.L., Degrauw T.J., Morehart P.J., and Bove K.E. Muscle coenzyme Q: a potential test for mitochondrial activity and redox status. Pediatr. Neurol. 32 (2005) 318-324
41. Montero R., Artuch R., Briones P., Nascimento A., Garcia-Cazorla A., Vilaseca M.A., Ja S.N.-A.Z., Navas P., Montoya J., and Pineda M. Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders. Biofactors 25 (2005) 109-115
42. Muller W., Reimers C.D., Berninger T., Boergen K.-P., Frey A., Zrenner E., and Al E. Coenzyme Q in opthalmoplegia plus - a double blind, cross over therapeutic trial. J. Neurol. Sci. 98 Suppl. (1990) 442 Abstract
43. Musumeci O., Naini A., Slonim A.E., Skavin N., Hadjigeorgiou G.L., Krawiecki N., Weissman B.M., Tsao C.Y., Mendell J.R., Shanske S., De Vivo D.C., Hirano M., and Dimauro S. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency. Neurology 56 7 (2001) 849-855
44. Ogasahara S., Engel A.G., Frens D., and Mack D. Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc. Natl. Acad. Sci. USA 86 (1989) 2379-2382
45. Ogasahara S., Nishikawa Y., Yorifuji S., Soga F., Nakamura Y., Takahashi M., Hashimoto S., Kono N., and Tarui S. Treatment of Kearns-Sayre syndrome with coenzyme Q10. Neurology 36 (1986) 45-53
46. Pepe, S., Marasco, S.F., Haas, S.J., F.L., S., H., K., & Rosenfeldt, F. (2007) Coenzyme Q10 in Cardiovascular Disease. Mitochondrion, in press.
47. Peterson P.L. The treatment of mitochondrial myopathies and encephalomyopathies. Biochim. Biophys. Acta 1271 (1995) 275-280
48. Quiles J.L., Ochoa J.J., Battino M., Gutierrez-Rios P., Nepomuceno E.A., Frias M.L., Huertas J.R., and Mataix J. Life-long supplementation with a low dosage of coenzyme Q10 in the rat: effects on antioxidant status and DNA damage. Biofactors 25 (2005) 73-86
49. Quinzii C.M., Dimauro S., and Hirano M. Human coenzyme Q(10) deficiency. Neurochem. Res. 32 4-5 (2007) 723-727
50. Quinzii C.M., Kattah A.G., Naini A., Akman H.O., Mootha V.K., Dimauro S., and Hirano M. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation. Neurology 64 (2005) 539-541
51. Rebrin I., Kamzalov S., and Sohal R.S. Tissue bioavailability and detection of coenzyme Q. Methods Enzymol. 378 (2004) 138-145
52. Rodriguez M.C., Macdonald J.R., Mahoney D.J., Parise G., Beal M.F., and Tarnopolsky M.A. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35 (2007) 235-242
53. Rosenfeldt F., Marasco S., Lyon W., Wowk M., Sheeran F., Bailey M., Esmore D., Davis B., Pick A., Rabinov M., Smith J., Nagley P., and Pepe S. Coenzyme Q10 therapy before cardiac surgery improves mitochondrial function and in vitro contractility of myocardial tissue. J. Thorac. Cardiovasc. Surg. 129 (2005) 25-32
54. Rotig A., Appelkvist E.L., Geromel V., Chretien D., Kadhom N., Edery P., Lebideau M., Dallner G., Munnich A., Ernster L., and Rustin P. Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency. Lancet 356 (2000) 391-395
55. Rundek T., Naini A., Sacco R., Coates K., and Dimauro S. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch. Neurol. 61 (2004) 889-892
56. Sackett D.L. Rules of evidence and clinical recommendations for the management of patients. Can. J. Cardiol. 9 (1993) 487-489
57. Salviati L., Sacconi S., Murer L., Zacchello G., Franceschini L., Laverda A.M., Basso G., Quinzii C., Angelini C., Hirano M., Naini A.B., Navas P., Dimauro S., and Montini G. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65 (2005) 606-608
58. Sander S., Coleman C.I., Patel A.A., Kluger J., and White C.M. The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J. Card. Fail. 12 (2006) 464-472
59. Sanderson S., Green A., Preece M.A., and Burton H. The incidence of inherited metabolic disorders in the West Midlands, UK. Arch. Dis. Child 91 (2006) 896-899
60. Scalori V., Alessandri M.G., Giovannini L., and Bertelli A. Plasma and tissue concentrations of coenzyme Q10 in the rat after intravenous, oral and topical administrations. Int. J. Tissue React. 12 (1990) 149-154
61. Schapira A.H. Mitochondrial disease. Lancet 368 (2006) 70-82
62. Shults C.W., Flint Beal M., Song D., and Fontaine D. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Exp. Neurol. 188 (2004) 491-494
63. Shults C.W., and Haas R. Clinical trials of coenzyme Q10 in neurological disorders. Biofactors 25 (2005) 117-126
64. Shults C.W., Oakes D., Kieburtz K., Beal M.F., Haas R., Plumb S., Juncos J.L., Nutt J., Shoulson I., Carter J., Kompoliti K., Perlmutter J.S., Reich S., Stern M., Watts R.L., Kurlan R., Molho E., Harrison M., and Lew M. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch. Neurol. 59 (2002) 1541-1550
65. Skladal D., Halliday J., and Thorburn D.R. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126 (2003) 1905-1912
66. Suzuki S., Hinokio Y., Ohtomo M., Hirai M., Hirai A., Chiba M., Kasuga S., Satoh Y., Akai H., and Toyota T. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia 41 (1998) 584-588
67. Vissing J., Gansted U., and Quistorff B. Exercise intolerance in mitochondrial myopathy is not related to lactic acidosis. Ann. Neurol. 49 (2001) 672-676
68. Wallace D.C., Shoffner J.M., Trounce I., Brown M.D., Ballinger S.W., Corral-Debrinski M., Horton T., Jun A.S., and Lott M.T. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim. Biophys. Acta 1271 (1995) 141-151
69. Wei Y.H., Lu C.Y., Wei C.Y., Ma Y.S., and Lee H.C. Oxidative stress in human aging and mitochondrial disease-consequences of defective mitochondrial respiration and impaired antioxidant enzyme system. Chin. J. Physiol. 44 (2001) 1-11
70. Yuzuriha T., Takada M., and Katayama K. Transport of [14C]coenzyme Q10 from the liver to other tissues after intravenous administration to guinea pigs. Biochim. Biophys. Acta 759 (1983) 286-291
71. Zhang Y., Aberg F., Appelkvist E.L., Dallner G., and Ernster L. Uptake of dietary coenzyme Q supplement is limited in rats. J. Nutr. 125 (1995) 446-453
72. Zierz S., Jahns G., and Jerusalem F. Coenzyme Q in serum and muscle of 5 patients with Kearns-Sayre syndrome and 12 patients with ophthalmoplegia plus. J. Neurol. 236 (1989) 97-101